Javascript must be enabled to continue!
Manic switch during vortioxetine treatment: New medicine, new issue
View through CrossRef
Antidepressants have been linked to manic or hypomanic episodes in patient being treated for unipolar or bipolar depression. Knowledge of the risk of manic or hypomanic switch associated with a specific antidepressant assists clinicians in analyzing the risk-benefit ratio and finally prescribing an antidepressant of choice in a specific instance. Vortioxetine is now frequently utilized in clinical practice to treat unipolar depression. However, there is insufficient data on manic or hypomanic transition during vortioxetine treatment of unipolar depression. The purpose of this case report is to add to the existing literature on the vortioxetine-induced manic switch and the importance of considering risk factors before starting anti-depressants. Vortioxetine should be used with caution in patients with mood disorders.
Scientific Scholar
Title: Manic switch during vortioxetine treatment: New medicine, new issue
Description:
Antidepressants have been linked to manic or hypomanic episodes in patient being treated for unipolar or bipolar depression.
Knowledge of the risk of manic or hypomanic switch associated with a specific antidepressant assists clinicians in analyzing the risk-benefit ratio and finally prescribing an antidepressant of choice in a specific instance.
Vortioxetine is now frequently utilized in clinical practice to treat unipolar depression.
However, there is insufficient data on manic or hypomanic transition during vortioxetine treatment of unipolar depression.
The purpose of this case report is to add to the existing literature on the vortioxetine-induced manic switch and the importance of considering risk factors before starting anti-depressants.
Vortioxetine should be used with caution in patients with mood disorders.
Related Results
Post-marketing safety surveillance of vortioxetine: a real-world study using the FAERS database
Post-marketing safety surveillance of vortioxetine: a real-world study using the FAERS database
Aims: The FDA Adverse Event Reporting System (FAERS) database was used
to study vortioxetine-associated adverse events (ADEs) in a real-world
setting to provide recommendations for...
Hepatic Inflammation and Apoptosis in Socially Isolated Rats: Effects of Vortioxetine Treatment
Hepatic Inflammation and Apoptosis in Socially Isolated Rats: Effects of Vortioxetine Treatment
Background: Depression and chronic psychosocial stress can induce systemic inflammation and oxidative stress that may extend beyond the central nervous system to peripheral organs ...
Efficacy and safety of vortioxetine in cardiological patients
Efficacy and safety of vortioxetine in cardiological patients
IntroductionThe most important conditions for the using of antidepressants in cardiological practice are good tolerability, minimal interaction with other drugs, and the absence of...
PREVIDA- IMPACT OF VORTIOXETINE ON MAJOR DEPRESSIVE DISORDER AND PERCEIVED COGNITIVE DYSFUNCTION: A MULTICENTER STUDY
PREVIDA- IMPACT OF VORTIOXETINE ON MAJOR DEPRESSIVE DISORDER AND PERCEIVED COGNITIVE DYSFUNCTION: A MULTICENTER STUDY
Objective: To find out how common cognitive impairment is in people with major depressive disorder (MDD) and assess how well vortioxetine works for treating both cognitive dysfunct...
The Account of the Effect of Switch Probability on Switch and Mixing Costs: An ERP Study in a Cued Task-switching Paradigm
The Account of the Effect of Switch Probability on Switch and Mixing Costs: An ERP Study in a Cued Task-switching Paradigm
Background:
Whether the effect of switch probability on switch and mixing costs is explained by an activation or preparation account is unclear.
...
Cannabis Withdrawal Induced Mania. A two year observational study of Hospital admissions from 2015 to 2019
Cannabis Withdrawal Induced Mania. A two year observational study of Hospital admissions from 2015 to 2019
IntroductionBipolar disorder (BD) is a recurrent psychiatric illness characterized by manic, hypo-manic, depressive and mixed episodes. The endocannabinoid system (ECS) is a vast n...
Vortioxetine for generalised anxiety disorder in adults
Vortioxetine for generalised anxiety disorder in adults
INTRODUCTION The currently accepted psychopharmacological treatment for generalised anxiety disorder in adults is associated with several adverse effects which threaten its accepta...
0766 Real-World Experience of Once-Nightly Sodium Oxybate Treatment in People with Narcolepsy: Final Results from REFRESH
0766 Real-World Experience of Once-Nightly Sodium Oxybate Treatment in People with Narcolepsy: Final Results from REFRESH
Abstract
Introduction
Oxybate treatment improves quality of life (QOL) for people with narcolepsy; however, the middle-of...

